{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T15:09:28Z","timestamp":1764688168800,"version":"3.46.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"crossref","award":["H2022206478"],"award-info":[{"award-number":["H2022206478"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-12095-8","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T15:00:39Z","timestamp":1764687639000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A columnar graphical prediction model for hepatic encephalopathy secondary to decompensated cirrhosis in hepatitis B cirrhosis"],"prefix":"10.1186","volume":"25","author":[{"given":"Yuxuan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengnan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shijie","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luonan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengxue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"issue":"10","key":"12095_CR1","first-page":"721","volume":"26","author":"Chinese Society of Hepatology, Chinese Medical Association","year":"2018","unstructured":"Chinese Society of Hepatology, Chinese Medical Association. Guidelines for the diagnosis and management of hepatic encephalopathy in cirrhosis. Zhonghua Gan Zang Bing Za Zhi. 2018;26(10):721\u201336. Chinese.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"1","key":"12095_CR2","doi-asserted-by":"publisher","first-page":"19544","DOI":"10.1038\/s41598-023-47012-z","volume":"13","author":"C Yao","year":"2023","unstructured":"Yao C, Huang L, Wang M, Mao D, Wang M, Zheng J, et al. Establishment and validation of a nomogram model for riskprediction of hepatic encephalopathy: a retrospective analysis. Sci Rep. 2023;13(1):19544.","journal-title":"Sci Rep"},{"issue":"27","key":"12095_CR3","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.3748\/wjg.v25.i27.3527","volume":"25","author":"TY Li","year":"2019","unstructured":"Li TY, Yang Y, Zhou G, Tu ZK. Immune suppression in chronic hepatitis B infection associated liver disease: A review. World J Gastroenterol. 2019;25(27):3527\u201337.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"12095_CR4","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jhep.2017.10.020","volume":"68","author":"G D\u2019Amico","year":"2018","unstructured":"D\u2019Amico G, Morabito A, D\u2019Amico M, Pasta L, Malizia G, Rebora P, et al. Clinical States of cirrhosis and competing risks. J Hepatol. 2018;68(3):563\u201376.","journal-title":"J Hepatol"},{"issue":"2","key":"12095_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jhep.2013.10.023","volume":"60","author":"G D\u2019Amico","year":"2014","unstructured":"D\u2019Amico G. The clinical course of cirrhosis. Population based studies and the need of personalized medicine. J Hepatol. 2014;60(2):241\u20132.","journal-title":"J Hepatol"},{"issue":"11","key":"12095_CR6","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1002\/hep4.1425","volume":"3","author":"EB Tapper","year":"2019","unstructured":"Tapper EB, Henderson JB, Parikh ND, Ioannou GN, Lok AS. Incidence of and risk factors for hepatic encephalopathy in a Population-Based cohort of Americans with cirrhosis. Hepatol Commun. 2019;3(11):1510\u20139.","journal-title":"Hepatol Commun"},{"key":"12095_CR7","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Regueiro JA, Higuera-de la Tijera MF, Moreno-Alc\u00e1ntar R, Torre A. Pathophysiology of hepatic encephalopathy and future treatment options. Rev gastroenterol Mex (Engl Ed). 2019 Apr-Jun;84(2):195\u2013203. English, Spanish.","DOI":"10.1016\/j.rgmxen.2019.05.001"},{"issue":"1","key":"12095_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/MEG.0b013e3283417567","volume":"23","author":"M Bismuth","year":"2011","unstructured":"Bismuth M, Funakoshi N, Cadranel JF, Blanc P. Hepatic encephalopathy: from pathophysiology to therapeutic management. Eur J Gastroenterol Hepatol. 2011;23(1):8\u201322.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"12095_CR9","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.1016\/j.jceh.2014.04.004","volume":"5","author":"P Sharma","year":"2015","unstructured":"Sharma P, Sharma BC. Management of overt hepatic encephalopathy. J Clin Exp Hepatol. 2015;5(Suppl 1):S82\u20137.","journal-title":"J Clin Exp Hepatol"},{"issue":"3","key":"12095_CR10","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jcrc.2009.01.008","volume":"24","author":"J Fichet","year":"2009","unstructured":"Fichet J, Mercier E, Gen\u00e9e O, Garot D, Legras A, Dequin PF, et al. Prognosis and 1-year mortality of intensive care unit patients with severe hepatic encephalopathy. J Crit Care. 2009;24(3):364\u201370.","journal-title":"J Crit Care"},{"issue":"1","key":"12095_CR11","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","volume":"58","author":"Robert Tibshirani","year":"1996","unstructured":"Robert Tibshirani. Regression shrinkage and selection via the Lasso. J Roy Stat Soc: Ser B (Methodol). 1996;58(1):267\u201388.","journal-title":"J Roy Stat Soc: Ser B (Methodol)"},{"issue":"12","key":"12095_CR12","first-page":"1309","volume":"30","author":"Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association","year":"2022","unstructured":"Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association. Guidelines for the prevention and treatment of chronic hepatitis B (version 2022). Zhonghua Gan Zang Bing Za Zhi. 2022;30(12):1309\u201331. Chinese.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"9","key":"12095_CR13","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.3390\/nu12092652","volume":"12","author":"AJ McEligot","year":"2020","unstructured":"McEligot AJ, Poynor V, Sharma R, Panangadan A. Logistic LASSO regression for dietary intakes and breast cancer. Nutrients. 2020;12(9):2652.","journal-title":"Nutrients"},{"issue":"3","key":"12095_CR14","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.jhep.2014.05.042","volume":"61","author":"American Association for the Study of Liver Diseases; European Association for the Study of the Liver","year":"2014","unstructured":"American Association for the Study of Liver Diseases; European Association for the Study of the Liver. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European association for the study of the liver and the American association for the study of liver diseases. J Hepatol. 2014;61(3):642\u201359.","journal-title":"J Hepatol"},{"issue":"1","key":"12095_CR15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/ajg.2015.377","volume":"111","author":"S Allampati","year":"2016","unstructured":"Allampati S, Duarte-Rojo A, Thacker LR, Patidar KR, White MB, Klair JS, et al. Diagnosis of minimal hepatic encephalopathy using Stroop encephalapp: A multicenter US-Based, Norm-Based study. Am J Gastroenterol. 2016;111(1):78\u201386.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"12095_CR16","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1002\/hep.29628","volume":"68","author":"EB Tapper","year":"2018","unstructured":"Tapper EB, Parikh ND, Sengupta N, Mellinger J, Ratz D, Lok AS, et al. A risk score to predict the development of hepatic encephalopathy in a population-based cohort of patients with cirrhosis. Hepatology. 2018;68(4):1498\u2013507.","journal-title":"Hepatology"},{"issue":"7","key":"12095_CR17","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.cgh.2014.12.025","volume":"13","author":"O Riggio","year":"2015","unstructured":"Riggio O, Amodio P, Farcomeni A, Merli M, Nardelli S, Pasquale C, et al. A model for predicting development of overt hepatic encephalopathy in patients with cirrhosis. Clin Gastroenterol Hepatol. 2015;13(7):1346\u201352.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"30","key":"12095_CR18","doi-asserted-by":"publisher","first-page":"4984","DOI":"10.3748\/wjg.v19.i30.4984","volume":"19","author":"JY Wang","year":"2013","unstructured":"Wang JY, Zhang NP, Chi BR, Mi YQ, Meng LN, Liu YD, et al. Prevalence of minimal hepatic encephalopathy and quality of life evaluations in hospitalized cirrhotic patients in China. World J Gastroenterol. 2013;19(30):4984\u201391.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"12095_CR19","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/apt.15915","volume":"52","author":"C Labenz","year":"2020","unstructured":"Labenz C, Nagel M, Kremer WM, Hilscher M, Schilling CA, Toenges G, et al. Association between diabetes mellitus and hepatic encephalopathy in patients with cirrhosis. Aliment Pharmacol Ther. 2020;52(3):527\u201336.","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"12095_CR20","first-page":"1228","volume":"41","author":"Z Qian","year":"2021","unstructured":"Qian Z, Yang Y. Modeling and evaluation of screening for cirrhosis complicated by mild hepatic encephalopathy. J Shanghai Jiao Tong Univ (Medical Edition). 2021;41(9):1228\u201332.","journal-title":"J Shanghai Jiao Tong Univ (Medical Edition)"},{"issue":"6","key":"12095_CR21","first-page":"982","volume":"40","author":"Q She","year":"2019","unstructured":"She Q, Chen M. Clinical characteristics of cirrhosis in patients with different glucose-metabolism States. Med J Wuhan Univ. 2019;40(6):982\u20136.","journal-title":"Med J Wuhan Univ"},{"issue":"6","key":"12095_CR22","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s12664-021-01150-2","volume":"40","author":"A Rattanasupar","year":"2021","unstructured":"Rattanasupar A, Chang A, Akarapatima K, Chaojin T, Piratvisuth T. Role of lactulose for prophylaxis against hepatic encephalopathy in cirrhotic patients with upper Gastrointestinal bleeding: A randomized trial. Indian J Gastroenterol. 2021;40(6):621\u20139.","journal-title":"Indian J Gastroenterol"},{"issue":"2","key":"12095_CR23","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1159\/000346083","volume":"87","author":"J Wen","year":"2013","unstructured":"Wen J, Liu Q, Song J, Tong M, Peng L, Liang H. Lactulose is highly potential in prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper Gastrointestinal bleeding: results of a controlled randomized trial. Digestion. 2013;87(2):132\u20138.","journal-title":"Digestion"},{"issue":"8","key":"12095_CR24","first-page":"916","volume":"28","author":"J Zhang","year":"2023","unstructured":"Zhang J, Wang Z, Yang J. Construction and validation of a predictive model for the risk of secondary hepatic encephalopathy in patients with chronic hepatitis B cirrhosis. Chin Hepatol. 2023;28(8):916\u201320.","journal-title":"Chin Hepatol"},{"issue":"3","key":"12095_CR25","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.jhep.2014.10.028","volume":"62","author":"M Merli","year":"2015","unstructured":"Merli M, Riggio O. Interaction between infection and hepatic encephalopathy. J Hepatol. 2015;62(3):746\u20137.","journal-title":"J Hepatol"},{"issue":"8","key":"12095_CR26","first-page":"654","volume":"45","author":"L Wang","year":"2006","unstructured":"Wang L, Cai J, Chen T, L\u00fc B, Si J. Influence of Helicobacter pylori infection on hyperammonemia and the onset of hepatic encephalopathy [J]. Chin J Intern Med. 2006;45(8):654\u20137. Chinese.","journal-title":"Chin J Intern Med"},{"issue":"5","key":"12095_CR27","doi-asserted-by":"publisher","first-page":"e0197127","DOI":"10.1371\/journal.pone.0197127","volume":"13","author":"LT Yuan","year":"2018","unstructured":"Yuan LT, Chuah SK, Yang SC, Liang CM, Wu CK, Tai WC, et al. Multiple bacterial infections increase the risk of hepatic encephalopathy in patients with cirrhosis. PLoS ONE. 2018;13(5):e0197127.","journal-title":"PLoS ONE"},{"issue":"1","key":"12095_CR28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1136\/gutjnl-2011-301255","volume":"62","author":"CD Tsien","year":"2013","unstructured":"Tsien CD, Rabie R, Wong F. Acute kidney injury in decompensated cirrhosis. Gut. 2013;62(1):131\u20137.","journal-title":"Gut"},{"issue":"10","key":"12095_CR29","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.3748\/wjg.v20.i10.2555","volume":"20","author":"M Bolognesi","year":"2014","unstructured":"Bolognesi M, Di Pascoli M, Verardo A, Gatta A. Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis. World J Gastroenterol. 2014;20(10):2555\u201363.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"12095_CR30","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ijid.2008.08.014","volume":"13","author":"L Chen","year":"2009","unstructured":"Chen L, Wu C, Fan X, Gao J, Yin H, Wang T, et al. Replication and infectivity of hepatitis B virus in HBV-related glomerulonephritis. Int J Infect Dis. 2009;13(3):394\u20138.","journal-title":"Int J Infect Dis"},{"issue":"6","key":"12095_CR31","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1038\/ajg.2009.293","volume":"104","author":"M Guevara","year":"2009","unstructured":"Guevara M, Baccaro ME, Torre A, G\u00f3mez-Ans\u00f3n B, R\u00edos J, Torres F, et al. Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis. Am J Gastroenterol. 2009;104(6):1382\u20139.","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"12095_CR32","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1111\/j.1478-3231.2010.02293.x","volume":"30","author":"M Guevara","year":"2010","unstructured":"Guevara M, Baccaro ME, R\u00edos J, Mart\u00edn-Llah\u00ed M, Uriz J, Ruiz del Arbol L, et al. Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration. Liver Int. 2010;30(8):1137\u201342.","journal-title":"Liver Int"},{"issue":"9","key":"12095_CR33","doi-asserted-by":"publisher","first-page":"724","DOI":"10.2298\/VSP0909724B","volume":"66","author":"D Benedeto-Stojanov","year":"2009","unstructured":"Benedeto-Stojanov D, Nagorni A, Bjelakovi\u0107 G, Stojanov D, Mladenovi\u0107 B, Djeni\u0107 N. The model for the end-stage liver disease and Child-Pugh score in predicting prognosis in patients with liver cirrhosis and esophageal variceal bleeding. Vojnosanit Pregl. 2009;66(9):724\u20138.","journal-title":"Vojnosanit Pregl"},{"issue":"1","key":"12095_CR34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.cld.2011.12.006","volume":"16","author":"KD Mullen","year":"2012","unstructured":"Mullen KD, Prakash RK. Management of Covert hepatic encephalopathy. Clin Liver Dis. 2012;16(1):91\u20133.","journal-title":"Clin Liver Dis"},{"issue":"2","key":"12095_CR35","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jceh.2017.06.005","volume":"8","author":"A Bale","year":"2018","unstructured":"Bale A, Pai CG, Shetty S, Balaraju G, Shetty A. Prevalence of and factors associated with minimal hepatic encephalopathy in patients with cirrhosis of liver. J Clin Exp Hepatol. 2018;8(2):156\u201361.","journal-title":"J Clin Exp Hepatol"},{"key":"12095_CR36","doi-asserted-by":"publisher","first-page":"5623601","DOI":"10.1155\/2021\/5623601","volume":"2021","author":"Y Peng","year":"2021","unstructured":"Peng Y, Wei Q, Liu Y, Wu Z, Zhang H, Wu H, et al. Prediction and risk factors for prognosis of cirrhotic patients with hepatic encephalopathy. Gastroenterol Res Pract. 2021;2021:5623601.","journal-title":"Gastroenterol Res Pract"},{"issue":"6","key":"12095_CR37","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1007\/s11011-019-00490-5","volume":"34","author":"M Senzolo","year":"2019","unstructured":"Senzolo M, Zarantonello L, Formentin C, Orlando C, Beltrame R, Vuerich A, et al. Predictive value of induced hyperammonaemia and neuropsychiatric profiling in relation to the occurrence of post-TIPS hepatic encephalopathy. Metab Brain Dis. 2019;34(6):1803\u201312.","journal-title":"Metab Brain Dis"},{"issue":"4","key":"12095_CR38","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.jhep.2010.07.045","volume":"54","author":"DL Shawcross","year":"2011","unstructured":"Shawcross DL, Sharifi Y, Canavan JB, Yeoman AD, Abeles RD, Taylor NJ, et al. Infection and systemic inflammation, not ammonia, are associated with grade 3\/4 hepatic encephalopathy, but not mortality in cirrhosis. J Hepatol. 2011;54(4):640\u20139.","journal-title":"J Hepatol"},{"issue":"19\u201320","key":"12095_CR39","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1007\/s00018-005-5089-0","volume":"62","author":"D Shawcross","year":"2005","unstructured":"Shawcross D, Jalan R. The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation. Cell Mol Life Sci. 2005;62(19\u201320):2295\u2013304.","journal-title":"Cell Mol Life Sci"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12095-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12095-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12095-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T15:00:44Z","timestamp":1764687644000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-12095-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12095"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12095-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"26 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed according to the Helsinki II Declaration and was approved by the ethics committee of the Second Hospital of Hebei Medical University, Shijiazhuang, China (Number: 2023-R567). The requirement for informed consent by individual patients was waived by the Ethical Committee of the Second Hospital of Hebei Medical University due to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1687"}}